Hemostemix Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was CAD 0.257243 million compared to CAD 0.810527 million a year ago. Basic loss per share from continuing operations was CAD 0.003 compared to CAD 0.011 a year ago.
For the nine months, net loss was CAD 1.82 million compared to CAD 3.89 million a year ago. Basic loss per share from continuing operations was CAD 0.024 compared to CAD 0.062 a year ago.